The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Région Wallonne; Prov. Brabant Wallon; Arr. Nivelles
Location of affected unit(s)
Rixensart
Sector
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
386 jobs Number of planned job losses
Announcement Date
5 February 2020
Employment effect (start)
1 March 2020
Foreseen end date
Description
GlaxoSmithKline (GSK), a multinational pharmaceutical company, has announced a worldwide restructuring measure with direct repercussions for its facilities in Belgium, including globally its biggest centre of vaccine production. The company has indicated its intention to split up its different divisions into separate companies. The vaccine production facility in Rixensart will be automated in the coming years, requiring less employees to maintain production. The company has announced that 720 employee posts are at risk in the announced restructuring as well as 215 temporary posts. The majority of those affected will be white-collar workers. The restructuring measures are alarming as GSK is the largest private employer within the entire Walloon region. Trade unions were aware of the possibility of restructuring and job loss.They are however worried that more dismissals will follow in the future.
Update 30/9/20: At the end of September the company announced that after negotiations with the trade unions (as stipulated in the 'Renault-Law') the amount of dismissals that will ultimately take place have been reduced to 386 instead of 720.
Eurofound (2020), GlaxoSmithKline, Internal restructuring in Belgium, factsheet number 99738, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/99738.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
